Aucune offre ouverte pour le moment.
Fresenius SE plans to cut 2,000 jobs globally at its generic drugs unit Kabi, or around 5% of the unit's workforce, as part of an efficiency programme, as reported by Handelsblatt.
Aucun avis pour le moment.